High satisfaction rates are achieved and sustained in subjects treated with onabotulinumtoxinA for GL and CFL combined.
No takes yet. Share an insight, caveat, or question.
Rivers et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: